peginterferon alfa-2a 180 MCG in 1 ML Injection
- RxCUI
- 351270
- RxNorm name
- peginterferon alfa-2a 180 MCG in 1 ML Injection
- Display name
- peginterferon alfa-2a 180 MCG in 1 ML Injection
- Full name
- peginterferon alfa-2a 180 MCG in 1 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:23
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103964 | Pegasys | peginterferon alfa-2a | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pegasys | PEGINTERFERON ALFA-2A | pharmaand GmbH | d9290e5b-6d40-2318-e053-2995a90a9916 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 351270 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d9290e5b-6d40-2318-e053-2995a90a9916 | peginterferon alfa-2a 180 MCG in 1 ML Injection | PSN | 44 | These highlights do not include all the information needed to use PEGASYS safely and effectively. See full prescribing information for PEGASYS. PEGASYS® (peginterferon alfa-2a) injection, for subcutaneous use Initial U.S. Approval: 2002 | 20250811 |
| d9290e5b-6d40-2318-e053-2995a90a9916 | peginterferon alfa-2a 180 MCG/ML Injectable Solution | SY | 44 | These highlights do not include all the information needed to use PEGASYS safely and effectively. See full prescribing information for PEGASYS. PEGASYS® (peginterferon alfa-2a) injection, for subcutaneous use Initial U.S. Approval: 2002 | 20250811 |
| d9290e5b-6d40-2318-e053-2995a90a9916 | 1 ML peginterferon alfa-2a 0.18 MG/ML Injection | SCD | 44 | These highlights do not include all the information needed to use PEGASYS safely and effectively. See full prescribing information for PEGASYS. PEGASYS® (peginterferon alfa-2a) injection, for subcutaneous use Initial U.S. Approval: 2002 | 20250811 |